Blueberry Therapeutics
Alderley Edge
About Blueberry Therapeutics
Blueberry Therapeutics Ltd. is a modern drug discovery and development company which puts people first whether patients, employees, investors or partners. We have created an open, imaginative and fun team environment with a very serious objective: to create new, safer and more effective medicines to treat human disease and make patients feel better. Blueberry focuses on the research and development of treatments for inflammatory and infectious diseases. We do this by employing state of the art preclinical research technologies to generate potent selective and safe molecules (peptides, antibodies, small molecules) for clinical development into new effective treatments to benefit patients. By focusing on well validated drug targets and ensuring our candidate molecules have a very low toxicity liability we believe we can mitigate or even avoid two of the major reasons for drug failures in the clinic.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $23.2M
- Last round: Series Unknown (Jun 2021)
- Website: blueberrytherapeutics.com
- Phone: +01625238776
Industries & Categories
Biotechnology, Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/blueberry-therapeutics-127841 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.